<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font33 { font-size : 33; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font27 { font-size : 27; } .font29 { font-size : 29; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font33">treatment </span>
   <span class="font30">IFN-I </span>
   <span class="font29">coronavirus </span>
   <span class="font27">{border-style </span>
   <span class="font26">respiratory </span>
   <span class="font25">px;} </span>
   <span class="font24">#ffffff;} </span>
   <span class="font24">clinical </span>
   <span class="font24">combination </span>
   <span class="font23">COVID- </span>
   <span class="font23">interferon </span>
   <span class="font21">SARS-CoV </span>
   <span class="font20">syndrome </span>
   <span class="font19">MERS-CoV </span>
   <span class="font19">acute </span>
   <span class="font18">viral </span>
   <span class="font17">IFNβ </span>
   <span class="font17">SARS-CoV- </span>
   <span class="font17">lopinavir/ritonavir </span>
   <span class="font17">replication </span>
   <span class="font16">px; </span>
   <span class="font16">ribavirin </span>
   <span class="font16">type </span>
   <span class="font16">vitro </span>
   <span class="font16">{font-family </span>
   <span class="font16">antiviral </span>
   <span class="font16">early </span>
   <span class="font16">font-size </span>
   <span class="font16">severe </span>
   <span class="font16">used </span>
   <span class="font15">cell </span>
   <span class="font15">data </span>
   <span class="font15">double; </span>
   <span class="font15">patients </span>
   <span class="font15">trial </span>
   <span class="font14">East </span>
   <span class="font14">Elsevier </span>
   <span class="font14">Middle </span>
   <span class="font14">border-color </span>
   <span class="font14">border-width </span>
   <span class="font14">disease </span>
   <span class="font14">drugs </span>
   <span class="font14">example, </span>
   <span class="font14">human </span>
   <span class="font14">infection </span>
   <span class="font14">interferons </span>
   <span class="font14">numerous </span>
   <span class="font14">potential </span>
   <span class="font14">solid; </span>
   <span class="font14">studies </span>
   <span class="font14">study </span>
   <span class="font14">{font-style </span>
   <span class="font14">{font-weight </span>
   <span class="font13">(Chan </span>
   <span class="font13">(Lokugamage </span>
   <span class="font13">COVID-. </span>
   <span class="font13">IFNα </span>
   <span class="font13">IFNβb </span>
   <span class="font13">Infect. </span>
   <span class="font13">administered </span>
   <span class="font13">administration </span>
   <span class="font13">bold </span>
   <span class="font13">centre </span>
   <span class="font13">coronaviruses </span>
   <span class="font13">courier; </span>
   <span class="font13">effect </span>
   <span class="font13">efficient </span>
   <span class="font13">em; </span>
   <span class="font13">factors </span>
   <span class="font13">inhibit </span>
   <span class="font13">mortality </span>
   <span class="font13">novel </span>
   <span class="font13">proteins </span>
   <span class="font13">pt;} </span>
   <span class="font13">research </span>
   <span class="font13">resource </span>
   <span class="font13">sensitive </span>
   <span class="font13">treat </span>
   <span class="font13">treatments </span>
  </p>
 </body>
</html>
